Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk model

Journal of Human Hypertension volume 39, pages 598–599 (2025)Cite this article

Subjects

Access through your institution
Buy or subscribe

We read with great interest the recent article from Minetto and colleagues presenting a novel clinical prediction model to identify patients with masked hypertension (MH) [1].

Using simple clinical parameters (office diastolic blood pressure, waist circumference, pulse pressure, male sex) the authors propose a new scoring system with a high specificity to identify patients at risk for MH/MUCH [1, 2]. The establishment of such scoring systems is of high clinical relevance, as patients with MH/MUCH suffer from an increased cardiovascular risk and require optimal hypertension treatment.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Minetto J, Espeche W, Leiva Sisnieguez CE, Cerri G, Perez Duhalde JI, Olano D, et al. Clinical prediction model for masked hypertension diagnosed by 24-h ambulatory blood pressure measurements in a sample from specialized hospital. J Hum Hypertens. 2025;39:199–204.

    Article  PubMed  CAS  Google Scholar 

  2. Ponce-Acosta C, Antonio-Villa NE. Can we detect masked hypertension and masked uncontrolled hypertension using simple metrics? A novel clinical model for latino population. J Hum Hypertens. 2025;39:189–91.

    Article  PubMed  Google Scholar 

  3. Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335–47.

    Article  PubMed  Google Scholar 

  4. Stefan N, Yki-Järvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13:134–48.

    Article  PubMed  CAS  Google Scholar 

  5. Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:903–13.

    Article  PubMed  Google Scholar 

  6. Sripongpun P, Kaewdech A, Udompap P, Kim WR. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score. JHEP Rep. 2024;6:101127.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res. Cardiol. 2021;110:921–37.

    Article  PubMed  Google Scholar 

  8. Kasper P, Martin A, Meyer zu Schwabedissen A, Scherdel J, Lang S, Goeser T, et al. Uncontrolled hypertension: a neglected risk in patients with NAFLD. J Intern Med. 2022;292:162–4.

    Article  PubMed  Google Scholar 

  9. Martin A, Lang S, Schifferdecker F, Allo G, Chon S-H, Neumann-Haefelin C, et al. Nocturnal hypertension represents an uncontrolled burden in patients with metabolic dysfunction-associated steatotic liver disease. J Hypertens. 2025;43:814–21.

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

The study was supported by Dr. Falk Pharma GmbH (Freiburg, Germany).

Author information

Authors and Affiliations

  1. Faculty of Medicine and University Hospital of Cologne, Department of Gastroenterology and Hepatology, University of Cologne, Cologne, Germany

    Philipp Kasper & Hans-Michael Steffen

  2. Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, (CVK) and Campus Charité Mitte (CCM), Berlin, Germany

    Münevver Demir

  3. Hypertension Center, University of Cologne, Cologne, Germany

    Hans-Michael Steffen

  4. Department of Postgraduate Studies and Research, Chreso University, Lusaka, Zambia

    Hans-Michael Steffen

Authors
  1. Philipp Kasper
    View author publications

    Search author on:PubMed Google Scholar

  2. Münevver Demir
    View author publications

    Search author on:PubMed Google Scholar

  3. Hans-Michael Steffen
    View author publications

    Search author on:PubMed Google Scholar

Contributions

PK, MD and HMS made substantial contributions to the analysis and interpretation of the data. PK and HMS drafted the manuscript. MD critically revised the manuscript for important intellectual content. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Philipp Kasper.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The study protocol was approved by the Ethics Committee of Cologne University’s Faculty of Medicine (No. 20-1048).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kasper, P., Demir, M. & Steffen, HM. Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk model. J Hum Hypertens 39, 598–599 (2025). https://doi.org/10.1038/s41371-025-01047-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41371-025-01047-z

Search

Advanced search

Quick links